Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.
AffiliationDepartment of Endocrinology, Christie Hospital National Health Service Trust, Withington, Manchester, United Kingdom.
MetadataShow full item record
AbstractPURPOSE: To evaluate testicular function in men after treatment with cytotoxic chemotherapy. PATIENTS AND METHODS: We measured testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels in 209 men after treatment with mechlorethamine, vinblastine, procarbazine, and prednisone, hybrid chemotherapy, or high-dose chemotherapy and in 54 healthy age-matched controls. RESULTS: The mean age of the patients was 38 years (range, 19 to 68 years), and all patients had received chemotherapy between 1 and 22 years previously. Patients had significantly higher mean LH (7.9 v 4.1 IU/L; P < .0001) and FSH levels (18.8 v 3.1 IU/L; P < .0001) than controls. There was no significant difference in mean total testosterone level between the patients and controls, but there was a trend toward a lower mean testosterone/SHBG ratio in the patients (0.63 v 0.7; P = .08). Analysis of the hormonal parameters using a model that allowed for the effects of increasing age on testicular function showed evidence of significant recovery of gonadal function in the first 10 years after treatment. Fifty-two percent of patients had LH levels at or above the upper limit of normal, and 32% of patients had increased LH with testosterone levels in the lower half of the normal range, suggesting a degree of Leydig cell impairment. CONCLUSION: In a significant proportion of men, there is good evidence of Leydig cell dysfunction after cytotoxic chemotherapy. The clinical significance of this Leydig cell dysfunction is not clear, but some of these men may benefit from testosterone replacement. Further studies are warranted.
CitationTesticular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. 1999, 17 (5):1493-8 J. Clin. Oncol.
JournalJournal of Clinical Oncology
- The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
- Authors: Tsatsoulis A, Whitehead E, St John J, Shalet SM, Robertson WR
- Issue date: 1987 Dec
- Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
- Authors: Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM
- Issue date: 1995 Jan
- Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
- Authors: Petersen PM, Skakkebaek NE, Vistisen K, Rørth M, Giwercman A
- Issue date: 1999 Mar
- Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
- Authors: Tsatsoulis A, Shalet SM, Morris ID, de Kretser DM
- Issue date: 1990
- Luteinizing hormone pulsatility in men with damage to the germinal epithelium.
- Authors: Talbot JA, Shalet SM, Tsatsoulis A, Grabinski M, Robertson WR
- Issue date: 1990 Jun